| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/11/07 | 07 : 03 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/11/07 | 00 : 30 | Edgar (US Regulatory) | Unknown (sec Staff) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/11/07 | 00 : 30 | Edgar (US Regulatory) | Unknown (sec Staff) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/08/30 | 05 : 31 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/08/29 | 19 : 46 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/08/07 | 20 : 02 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/08/07 | 19 : 44 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/10 | 22 : 32 | Edgar (US Regulatory) | Certification by the Exchange Approving Securities for Listing (cert) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 05 : 56 | Edgar (US Regulatory) | Securities Registration (section 12(b)) (8-a12b) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 05 : 41 | Edgar (US Regulatory) | Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme... | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 05 : 22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 05 : 22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 05 : 19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 05 : 17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 05 : 14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 05 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/06/08 | 03 : 20 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/05/30 | 01 : 58 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/05/29 | 05 : 10 | GlobeNewswire Inc. | Rexahn Announces Move to Nasdaq | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/05/13 | 21 : 00 | GlobeNewswire Inc. | Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/05/11 | 05 : 22 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/04/30 | 05 : 45 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/04/16 | 21 : 04 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/04/16 | 21 : 00 | GlobeNewswire Inc. | Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/04/12 | 21 : 16 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/04/12 | 21 : 00 | GlobeNewswire Inc. | Rexahn Effects 1-for-12 Reverse Stock Split | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/04/11 | 05 : 07 | GlobeNewswire Inc. | Rexahn Announces Reverse Stock Split | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/03/27 | 21 : 00 | GlobeNewswire Inc. | Rexahn Announces Multiple Presentations at the 2019 American Association for Cancer Research Annual Meeting | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/03/27 | 05 : 15 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 2019/03/11 | 19 : 55 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |